NEUROFRONT

neurofront-logo

Neurofront is a biotech company focused on the acquisition, development, and commercialization of transformative neuroscience medicines. The company is focusing on bringing the latest innovative medications from global neuroscience leaders to China and Asia.

#People #Website #More

NEUROFRONT

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2020-01-01

Address:
Pudong, Shandong, China

Country:
China

Website Url:
http://www.neurofrontrx.com

Total Employee:
1+

Status:
Active

Contact:
+86 21 68503071

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS ASP.NET


Current Employees Featured

gary-tong_image

Gary Tong
Gary Tong Co-Founder & CMO @ NeuroFront
Co-Founder & CMO
2020-09-01

june-yan_image

June Yan
June Yan Co-Founder & CEO @ NeuroFront
Co-Founder & CEO
2020-08-01

Founder


gary-tong_image

Gary Tong

june-yan_image

June Yan

Official Site Inspections

http://www.neurofrontrx.com

  • Host name: 204.11.56.37
  • IP address: 204.11.56.37
  • Location: British Virgin Islands
  • Latitude: 18.5
  • Longitude: -64.5
  • Timezone: America/Tortola

Loading ...

More informations about "NeuroFront"

NeuroFront - Crunchbase Company Profile & Funding

Organization. NeuroFront . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +86 21 โ€ฆSee details»

Neurofront - VentureRadar

Website: https://www.neurofrontrx.com/ Develops and commercializes transformative neuroscience medicines, addressing China-specific unmet medical needs with elite ...See details»

Neurofront 2025 Company Profile: Valuation, Funding โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Neurofront. Use the PitchBook Platform to explore the full profile.See details»

NeuroFront - Overview, News & Similar companies | ZoomInfo.com

View NeuroFront (www.neurofrontrx.com) location in Shanghai, China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

NeuroFront - Products, Competitors, Financials, Employees, โ€ฆ

Headquarters Location. Suite 2503, 25F, Tower 2, Century Link 1196 Century Avenue. Pudong, Shanghai, 200122, ChinaSee details»

June Yan - Chief Executive Officer - NeuroFront - ZoomInfo

View June Yan's business profile as Chief Executive Officer at NeuroFront. Find contact's direct phone number, email address, work history, and more.See details»

NeuroFront - Contacts, Employees, Board Members, Advisors

Organization. NeuroFront . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. NeuroFront has 2 current โ€ฆSee details»

NeuroFront - Crunchbase

Neurofront is a biotech company focused on the acquisition, development, and commercialization of transformative neuroscience medicines.See details»

NeuroFront Announces Exclusive Licensing Agreement for โ€ฆ

NeuroFront was established by top-tier life sciences investors and is led by an elite team of neuroscience industry veterans with substantial and compelling expertise in China and globally โ€ฆSee details»

Novaremed Enters Into an Exclusive Option and License โ€ฆ

Jul 21, 2022 For more information: www.neurofrontrx.com. About Novaremed Novaremed AG, a privately held clinical-stage biopharmaceutical company, is developing a pipeline of innovative โ€ฆSee details»

Neuro Front - Company Profile - Tracxn

Neuro Front - Developer of transformation medicines for neurological disorders. Raised funding from 2 investors. Founded by June Yan and Gary Tong in the year 2020. Neuro Front has 17 โ€ฆSee details»

Top "Biotech neuroscience" start-ups | VentureRadar

Neurofront. n/a. Founded 2020. China. NeuroFront is focused on acquiring, developing and commercializing transformative medicines in neuroscience. We aim to become an elite โ€ฆSee details»

Novaremed Enters Into an Exclusive Option and License โ€ฆ

Jul 21, 2022 NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremedโ€™s first-in-class, non-opioid โ€ฆSee details»

Neurolief Announces Exclusive Licensing Agreement with โ€ฆ

Jul 7, 2021 NeuroFront was established by top-tier life sciences investors and is led by an elite team of neuroscience industry veterans with substantial and compelling expertise in China and โ€ฆSee details»

Neurolief Announces Exclusive Licensing Agreement with โ€ฆ

Jul 7, 2021 For more information, please visit www.neurofrontrx.com. About Migraine Migraine is a common, disabling, and recurring complex neurological disorder with a genetic component, โ€ฆSee details»

Pivotal Bio | News - Novaremed enters into an exclusive option โ€ฆ

Basel, Switzerland, and Hong Kong, China, July 21, 2022โ€“ Novaremed AG and NeuroFront Therapeutics (Hong Kong) Limited jointly announce the signing of an exclusive collaboration โ€ฆSee details»

NeuroFront - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Neurofront is a biotech company focused on the acquisition, development, and commercialization of transformative neuroscience medicines.See details»

Novaremed agreement with NeuroFront for non-opioid โ€ฆ

Jul 21, 2022 NeuroFront receives an exclusive option for an exclusive license to develop, commercialize and manufacture NRD.E1, Novaremedโ€™s first-in-class, non-opioid โ€ฆSee details»

Novaremed Enters Into an Exclusive Option and License โ€ฆ

For more information: www.neurofrontrx.com. About Novaremed Novaremed AG, a privately held clinical-stage biopharmaceutical company, is developing a pipeline of innovative medications โ€ฆSee details»

NeuroFront Acquires Non-Opioid Neuropathic Pain Killer for $130 โ€ฆ

Jul 21, 2022 Hong Kongโ€™s NeuroFront Therapeutics acquired greater China rights to a novel non-opioid neuropathic pain drug from Switzerlandโ€™s Novaremed in a $130 million agreement. โ€ฆSee details»